I'm LongbridgeAI, I can summarize articles.Colgate (CL) slipped 0.36% this week to $90.75, while the S&P 500 gained 0.49%, leaving the stock about 85 basis points behind the benchmark. The week leaned into a choppy pullback: Monday (Aug 24) opened higher and hit the weekly high of $92.55, followed by two days of churn between $91.30 and $92.31. Thursday (Aug 27) dropped to the weekly low of $90.48 before a modest recovery, and Friday (Aug 28) closed at $90.75. Weekly amplitude was around 2.26%. Average daily volume of 3.
The Week
Colgate (CL) slipped 0.36% this week to $90.75, while the S&P 500 gained 0.49%, leaving the stock about 85 basis points behind the benchmark. The week leaned into a choppy pullback: Monday (Aug 24) opened higher and hit the weekly high of $92.55, followed by two days of churn between $91.30 and $92.31. Thursday (Aug 27) dropped to the weekly low of $90.48 before a modest recovery, and Friday (Aug 28) closed at $90.75. Weekly amplitude was around 2.26%. Average daily volume of 3.47m shares ran about 20% below the 60-day median, so turnover stayed on the quiet side.
Key Events
Company-specific news this week was concentrated in management transactions and investor outreach. On Tuesday (Aug 25), two market-level reports touching AI concepts and cross-sector restructuring floated around, but neither pointed to a concrete business change at Colgate. Thursday (Aug 27) carried the densest flow: COO Panagiotis Tsourapas sold 10,000 shares for roughly $920,000, drawing follow-up coverage from multiple outlets; the same day, Colgate announced a fireside chat webcast at the Barclays 2026 Global Consumer Staples Conference. No material filing appeared this week after routine Form 4 items were filtered out. Overall, the event line stayed light on company-driven catalysts, with a modest insider sale and a standard investor conference at the centre.
Analyst Ratings
Colgate is covered by 21 institutions. The breakdown is 7 buy ratings, 6 over ratings and 8 hold ratings, with no sell or under ratings. The consensus recommendation is buy, and the consensus target sits at $98.95, about 9.04% above the spot price of $90.75. The target range from $87 to $110 shows a fairly wide spread, suggesting analysts do not agree closely on the earnings trajectory ahead. Within the household cleaning products industry, Colgate ranks 2nd out of 12 comparable names in coverage ratings, placing it near the top of the group.
The Week Ahead
The coming week opens a dense stretch of US macro data. Monday (Aug 31) brings the Dallas Fed manufacturing business activity index. Tuesday (Sep 1) through Wednesday (Sep 2) deliver the S&P Global manufacturing PMI final, ISM manufacturing PMI, JOLTS job openings, ADP private employment and factory orders. As a consumer staples name, Colgate tends to show limited direct response to macro surprises, but shifts in risk appetite around labour and manufacturing figures could trigger sector rotation that feeds into the stock. On the company side, the next earnings report is the fiscal Q3 2026 release scheduled for October 30 before market open, so there is no Colgate-specific print during the week itself.
In Short
The tension this week runs in two directions. The rating structure stays constructive: consensus is still buy, with a target around 9% above spot and a top-two industry ranking. Yet the stock finished the week in the red, lagged the S&P 500 and traded roughly 20% below its median volume, signalling that capital has not flowed back simply on the strength of the rating backdrop. The small insider sale and the upcoming macro-heavy first week of September add to the things worth watching. The next leg likely turns on how consumer staples fare after the macro releases and whether any company-level catalyst emerges before the late-October earnings date.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.